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cancer chemotherapY
Improved compliance with adjuvant vinorelbine 
and cisplatin in non-small cell lung cancer
Aljubran and colleagues retrospectively evaluated compliance and 
toxicity of platinum-based chemotherapy in 50 patients in the 2 
years following reports of successful adjuvant chemotherapy for 
NSCLC. Eighty percent completed treatment, but 40% required 
a dose reduction and 58% required a delay in treatment. Six events 
of febrile neutropenia were reported in 5 patients and admission 
for toxicity was required in 5 other patients. There were no toxic 
deaths. The authors conclude that adjuvant-based chemotherapy 
for resected NSCLC is accepted by physicians and patients with 
a high degree of compliance.
stem cell therapY
A retrospective comparison of allogeneic 
peripheral blood stem cell versus bone marrow 
transplantation
Bittencourt and colleagues compared outcomes in 364 patients 
who received either allogeneic bone marrow (n=142) or periph-
eral blood stem cell (n=222) transplantation. Chronic myeloid 
leukemia was the diagnosis in 41% of patients. Patients who 
received a peripheral blood stem cell transplantation had faster 
neutrophil and platelet engraftment, but increased rates of acute 
graft-versus-host disease. There was no significant differences in 
chronic graft-versus-host disease, transplant-related mortality, 
relapse or survival rates. There was no clear benefit in relapse rate 
and no evidence that transplantation with peripheral stem cells 
benefits patient survival in their institution.
surViVal and outcomes
Clinical characteristics and outcome of pediatric 
patients with stage IV Hodgkin lymphoma
Belgaumi and colleagues studied outcomes from 1975 to 2003 in 
67 patients younger than 14 years of age with stage IV Hodgkin 
lymphoma treated from 1975 to 2003 at a single institution.  Fifty-
four patients (80.6%) achieved complete remission, 2 (3%) a partial 
remission, 10 (14.9%) had progressive disease, and 1 was lost to 
follow-up. Overall survival was 79.4% and event-free survival was 
63.9% at 5 years. Failure to achieve a complete remission with che-
motherapy was the only factor associated with a poorer outcome in 
a multivariate analysis. Slow responders who fail to achieve com-
plete remission may require novel and/or aggressive therapy.
cancer biochemistrY
Studies on biomarkers for oxidative stress in 
patients with chronic myeloid leukemia
Singh and colleagues compared plasma levels of products of 
protein oxidation and lipid peroxidation between patients with 
chronic (n=20) and accelerated phase CML (n=20). They found 
statistically significant differences in plasma levels of  protein car-
bonyl, thiobarbituric acid reactive substances, and total lipid hy-
droperoxide, and concluded that they might serve as biomarkers 
for oxidative stress in CML patients. Further studies are needed 
to establish their precise role.
GYnecoloGic oncoloGY
Polymorphic (CAG)n repeats in the androgen 
receptor gene: a marker for endometriosis and 
uterine leiomyomas
Shaik and colleagues compared the frequency of (CAG)n repeats 
in the androgen receptor gene in 90 women with endometriosis, 
140 with leiomyomas and 101 health age- and sex-matched con-
trols, all women of Asian Indian ethnic population. In patients 
with endometriosis, 19 CAG repeats were more frequent than in 
controls, and in patient with leiomyomas, 20 CAG repeats were 
more frequent than in controls.  The authors propose that these 
repeats of the androgen receptor gene are markers of high risk 
for these benign pathologies of the uterus, but that further stud-
ies are needed in different ethnic groups to understand the role 
of androgen receptor gene polymorphism in the development of 
endometriosis and leiomyomas.
